摘要
在近5年间,抗癌药的销售额达到了一个惊人的数字。在众多的抗肿瘤抗生素中,能够进入临床Ⅱ期的很少,获批上市的更少。本文对已上市的抗肿瘤抗生素、临床阶段的新型抗肿瘤抗生素、基础研究阶段的新型抗肿瘤抗生素这些处于各个发展阶段的抗肿瘤抗生素进行综述研究,相信未来能制造出更多更好的抗肿瘤抗生素药物制剂。
The sales of cancer drugs reached a staggering figure in recent five years.There were few antitumor antibiotics which was able to enter the period of clinicalⅡ.The antitumor antibiotics in various stages of development were reviewed in this paper.We believe that more and better antitumor antibiotic pharmaceutical preparations can be created in the future.
作者
王琳
WANG Lin(College of Pharmacy,Suzhou Vocational Health College,Suzhou 215009,China)
出处
《海峡药学》
2020年第12期94-97,共4页
Strait Pharmaceutical Journal
基金
苏州市科技局指导项目:碳酸酐酶Ⅸ抗体修饰去甲斑蝥素纳米胶束的抗肿瘤活性的研究(SYSD2017062)。
关键词
抗肿瘤
抗生素
靶向性
发展动态
Antitumor antibiotics
Targeting
Development
Trends
